EDEN Bioscience Corp. Announces Second Quarter Financial Results Release Date and Time.

Business Editors

BOTHELL, Wash.--(BUSINESS WIRE)--July 12, 2001

EDEN Bioscience Corporation (Nasdaq:EDEN) announced today that it plans to release the financial results of its second quarter 2001, ending June 30, 2001, after the close of regular market trading on Thursday, July 26, 2001.

The company will host a conference call featuring remarks by Jerry Butler, President and Chief Executive Officer, and Brad Powell, Chief Financial Officer at 5 p.m. EDT / 2 p.m. PDT. The public is invited to participate on a listen-only basis. A live Webcast and replay of the call will be available in the Investor Relations section of the company's Website, www.edenbio.com/in/inmain.html.

ABOUT EDEN Bioscience

EDEN Bioscience is a plant technology company focused on developing, manufacturing and marketing innovative natural products for agriculture. EDEN believes its technology and initial product, Messenger(R), allows it to offer superior alternatives to existing plant protection and crop yield enhancement products in terms of both performance and safety, and importantly, to avoid the substantial public resistance to many chemical pesticides and genetically modified plants. Messenger, which received EPA approval for full commercial use in April 2000, is based on naturally occurring proteins called "harpins," which trigger natural plant defense systems to protect against disease and pests, and simultaneously activate plant growth systems, improving crop yield and quality. EDEN Bioscience's headquarters are at 11816 North Creek Parkway N., Bothell, WA 98011, 425/806-7300; www.edenbio.com.